FDA approves AbbVie's VIEKIRA PAK for treatment of patients with GT1 HCV infection

Press/Media: Press / Media

PeriodDec 21 2014

Media coverage

1

Media coverage

  • TitleFDA approves AbbVie's VIEKIRA PAK for treatment of patients with GT1 HCV infection
    Media name/outletNews-Medical.Net
    CountryAustralia
    Date12/21/14
    PersonsFred Poordad